This brand name is authorized in South Africa
The drug MENCEVAX contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Meningococcal serogroup A polysaccharide vaccine
UNII 1I86B47NY4 - NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE ANTIGEN
|
|
|
|
2
Meningococcal serogroup C polysaccharide vaccine
UNII 9B7N7Y96MK - NEISSERIA MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CRM-197 ADIPIC ACID CONJUGATE
|
|
|
|
3
Meningococcal serogroup W135 polysaccharide vaccine
UNII 9F8QQ6EER1 - NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE ANTIGEN
|
|
|
|
4
Meningococcal serogroup Y polysaccharide vaccine
UNII CBZ4BH7TJ1 - NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE ANTIGEN
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J07AH04 | Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen | J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AH Meningococcal vaccines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 44/30.2/0039, X/30.1/259 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
